Y. Senga, G. Kimura, T. Hattori and K. Yoshida, “Clinical Evaluation of Soluble Cytokeratin 19 Fragments (CY-FRA 21-1) in Serum and Urine of Patients with Bladder Cancer,” Urology, Vol. 48, No. 5, 1996, pp. 703-710. doi:10.1016/S0090-4295(96)00253-1
 G. Gakis, J. Efstathiou, S. P. Lerner, et al., “ICUD-EAU International Consultation on Bladder Cancer 2012: Radical Cystectomy and Bladder Preservation for Muscle-Invasive Urothelial Carcinoma of the Bladder,” European Urology, Vol. 63, No. 1, 2013, pp. 45-57. doi:10.1016/j.eururo.2012.08.009
 H. Azuma, K. Yamamoto, T. Inamoto, et al., “Total Cystectomy versus Bladder Preservation Therapy for Locally Invasive Bladder Cancer: Effect of Combined Therapy Using Balloon-Occluded Arterial Infusion of Anticancer Agent and Hemodialysis with Concurrent Radiation,” American Journal of Clinical Oncology, Vol. 32, No. 6, 2009, pp. 592-606. doi:10.1097/COC.0b013e318199fb42
 H. Azuma, T. Inamoto, K. Takahara, et al., “Neoadjuvant and Adjuvant Chemotherapy for Locally Advanced Bladder Carcinoma: Development of Novel Bladder Preservation Approach, Osaka Medical College Regimen,” International Journal of Urology, Vol. 19, No. 1, 2012, pp. 26-38. doi:10.1111/j.1442-2042.2011.02856.x
 H. Azuma, T. Inamoto, N. Ibuki, et al., “Novel Bladder Preservation Therapy for Locally Invasive Bladder Cancer: Combined Therapy Using Balloon-Occluded Arterial Infusion of Anticancer Agent and Hemodialysis with Concurrent Radiation,” International Journal of Urology, Vol. 37, No. 4, 2010, pp. 773-785. doi:10.3892/ijo_00000727
 A. Mokarim, M. Uetani, I. Sakamoto, et al., “Transcatheter Arterial Infusion of Cisplatin and Doxorubicin in Bladder Cancer,” Acta Oncologica, Vol. 36, 1997, pp. 175-181. doi:10.3109/02841869709109227
 H. J. Yan, R. B. Wang, K. L. Zhu, et al., “Cytokeratin 19 Fragment Antigen 21-1 as an Independent Predictor for Definitive Chemoradiotherapy Sensitivity in Esophageal Squamous Cell Carcinoma,” Chinese Medical Journal (English Edition), Vol. 125, No. 8, 2012, pp. 1410-1415.
 Y. N. Fahmueller, D. Nagel, R. T. Hoffmann, et al., “Predictive and Prognostic Value of Circulating Nucleosomes and Serum Biomarkers in Patients with Metastasized Colorectal Cancer Undergoing Selective Internal Radiation Therapy,” BMC Cancer, Vol. 4, No. 12, 2012, p. 5.
 W. Sidney, P. C. Vincent, S. Melvin and J. Douglas, “Transcatheter Intraarterial Infusion of Chemotherapy in Advanced Bladder Cancer,” Cancer, Vol. 49, 1982, pp. 640-645. doi:10.1002/1097-0142(19820215)49:4<640::AID-CNCR2820490406>3.0.CO;2-6
 C. Andreadis, S. Touloupidis, G. Galaktidou, et al., “Serum CYFRA 21-1 in Patients with Invasive Bladder Cancer and Its Relevance as a Tumor Marker during Chemotherapy,” Journal of Urology, Vol. 174, No. 5, 2005, pp. 1771-1775. doi:10.1097/01.ju.0000176742.53556.25